Impact of drug distribution into adipose on tissue function: The cholesteryl ester transfer protein (CETP) inhibitor anacetrapib as a test case
Abstract Anacetrapib is an inhibitor of cholesteryl ester transfer protein (CETP) previously under development as a lipid‐modifying agent that reduces LDL‐cholesterol and increases HDL‐cholesterol in hypercholesterolemic patients. Anacetrapib demonstrates a long terminal half‐life and accumulates in...
Gardado en:
| Principais autores: | , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Wiley
2019-12-01
|
| Series: | Pharmacology Research & Perspectives |
| Assuntos: | |
| Acceso en liña: | https://doi.org/10.1002/prp2.543 |
| Tags: |
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|